Proteomics analysis reveals distinct corona composition on magnetic nanoparticles with different surface coatings: Implications for interactions with primary human macrophages

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Vogt, Carmen ^a,c   Pernemalm, Maria ^a   Kohonen, Pekka ^a   Laurent, Sophie ^b   Hultenby, Kjell ^a   Vahter, Marie ^a   Lehtiö, Janne ^a   Toprak, Muhammet S ^c   Fadeel, Bengt ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF MONS   (Belgium)

^c ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN; SILICON DIOXIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TUMOR NECROSIS FACTOR ALPHA; CONTRAST MEDIUM; FERRIC ION; FERRIC OXIDE; MAGNETITE NANOPARTICLE; PROTEIN BINDING; PROTEIN CORONA; SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; CELL INTERACTION; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; GENE ONTOLOGY; HUMAN; HUMAN CELL; INTERNALIZATION; INTRACELLULAR TRANSPORT; MACROPHAGE; MASS SPECTROMETRY; MATERIAL COATING; MOLECULAR DYNAMICS; MONOCYTE; PROTEIN ANALYSIS; PROTEIN STRUCTURE; PROTEOMICS; ADULT; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; ENDOCYTOSIS; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; PROCEDURES; SURFACE PROPERTY;

ADULT; CELL SURVIVAL; CELLS, CULTURED; CONTRAST MEDIA; DEXTRANS; ENDOCYTOSIS; FERRIC COMPOUNDS; HUMANS; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MASS SPECTROMETRY; PROTEIN BINDING; PROTEIN CORONA; SILICON DIOXIDE; SURFACE PROPERTIES;

EID: 84948680390     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0129008     Document Type: Article

References (35)

1. Pouliquen D, Le Jeune JJ, Perdrisot R, Ermias A, Jallet P. Iron oxide nanoparticles for use as an MRI contrast agent: Pharmacokinetics and metabolism. MRI. 1991; 9(3):275-83. doi: 10.1016/0730-725x (91)90412-f
2. Mahmoudi M, Sant S, Wang B, Laurent S, Sen T. Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy. Adv Drug Deliv Rev. 2011; 63(1-2):24-46. doi: 10.1016/j.addr.2010.05.006 PMID: 20685224
3. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 2005; 26(18):3995-4021. doi: 10.1016/j.biomaterials.2004.10.012 PMID: 15626447
4. Kunzmann A, Andersson B, Vogt C, Feliu N, Ye F, Gabrielsson S, et al. Efficient internalization of silicacoated iron oxide nanoparticles of different sizes by primary human macrophages and dendritic cells. Toxicol and Appl Pharmacol. 2011; 253(2):81-93. doi: 10.1016/j.taap.2011.03.011
5. Lynch I, Cedervall T, Lundqvist M, Cabaleiro-Lago C, Linse S, Dawson KA. The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Adv Colloid Interface Sci. 2007; 134-135:167-74. doi: 10.1016/j.cis.2007.04.021 PMID: 17574200
6. Nel AE, Mädler L, Velegol D, Xia T, Hoek EMV, Somasundaran P, et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater. 2009; 8:543-57. doi: 10.1038/nmat2442 PMID: 19525947
7. Walkey CD, Chan WC. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem Soc Rev. 2012; 41(7):2780-99. doi: 10.1039/c1cs15233e PMID: 22086677
8. Fadeel B, Feliu N, Vogt C, Abdelmonem AM, Parak WJ. Bridge over troubled waters: understanding the synthetic and biological identities of engineered nanomaterials. Wiley Interdiscip RevNanomed Nanobiotechnol. 2013; 5(2):111-29. doi: 10.1002/wnan.1206
9. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A. 2008; 105(38):14265-70. doi: 10.1073/pnas.0805135105 PMID: 18809927
10. Tenzer S, Docter D, Rosfa S, Wlodarski A, Kuharev J, Rekik A, et al. Nanoparticle Size Is a Critical Physicochemical Determinant of the Human Blood Plasma Corona: A Comprehensive Quantitative Proteomic Analysis. ACS Nano. 2011; 5(9):7155-67. doi: 10.1021/nn201950e PMID: 21866933
11. Docter D, Strieth S, Westmeier D, Hayden O, Gao M, Knauer SK, et al. No king without a crown- impact of the nanomaterial-protein corona on nanobiomedicine. Nanomedicine. 2015; 10(3):503-19. doi: 10.2217/nnm.14.184 PMID: 25707981
12. Vogt C, Toprak M, Muhammed M, Laurent S, Bridot J-L, Müller R. High quality and tuneable silica shell-magnetic core nanoparticles. J Nanopart Res. 2010; 12(4):1137-47. doi: 10.1007/s11051-009- 9661-7
13. Witasp E, Kupferschmidt N, Bengtsson L, Hultenby K, Smedman C, Paulie S, et al. Efficient internalization of mesoporous silica particles of different sizes by primary human macrophages without impairment of macrophage clearance of apoptotic or antibody-opsonized target cells. Toxic Appl Pharmacol. 2009; 239(3):306-19. doi: 10.1016/j.taap.2009.06.011 PMID: 19538981
14. Krais A, Wortmann L, Hermanns L, Feliu N, Vahter M, Stucky S, et al. Targeted uptake of folic acidfunctionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum. Nanomedicine. 2014; 10(7):1421-31. doi: 10.1016/j.nano.2014.01.006 PMID: 24491397
15. Pernemalm M, Lehtiö J. A Novel Prefractionation Method Combining Protein and Peptide Isoelectric Focusing in Immobilized pH Gradient Strips. J Proteome Res. 2013; 12(2):1014-9. doi: 10.1021/ pr300817y PMID: 23214937
16. Eng JK, McCormack AL, Yates JR. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom. 1994; 5(11):976-89. doi: 10.1016/1044-0305(94)80016-2 PMID: 24226387
17. Vizcaíno JA, Côté RG, Csordas A, Dianes JA, Fabregat A, Foster JM, et al. The Proteomics Identifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res. 2013; 41(D1):D1063-D9. doi: 10.1093/nar/gks1262
18. Kunzmann A, Andersson B, Thurnherr T, Krug H, Scheynius A, Fadeel B. Toxicology of engineered nanomaterials: Focus on biocompatibility, biodistribution and biodegradation. Biochim Biophys Acta General Subjects. 2011; 1810(3):361-73. http://dx.doi.org/10.1016/j.bbagen.2010.04.007.
19. Deng ZJ, Liang M, Monteiro M, Toth I, Minchin RF. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat Nano. 2011; 6(1):39-44. doi: 10.1038/nnano. 2010.250
20. Wang F, Yu L, Monopoli MP, Sandin P, Mahon E, Salvati A, et al. The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes. Nanomedicine. 2013; 9(8):1159-68. doi: 10.1016/j.nano.2013.04.010 PMID: 23660460
21. Dutta D, Sundaram SK, Teeguarden JG, Riley BJ, Fifield LS, Jacobs JM, et al. Adsorbed Proteins Influence the Biological Activity and Molecular Targeting of Nanomaterials. Toxicol Sci. 2007; 100(1):303-15. doi: 10.1093/toxsci/kfm217 PMID: 17709331
22. Tenzer S, Docter D, Kuharev J, Musyanovych A, Fetz V, Hecht R, et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nano. 2013; 8(10):772-81. doi: 10. 1038/nnano.2013.181
23. Amiri H, Bordonali L, Lascialfari A, Wan S, Monopoli MP, Lynch I, et al. Protein corona affects the relaxivity and MRI contrast efficiency of magnetic nanoparticles. Nanoscale. 2013; 5(18):8656-65. doi: 10. 1039/c3nr00345k PMID: 23896964
24. Pinho SLC, Laurent S, Rocha J, Roch A, Delville M- H, Mornet S, et al. Relaxometric Studies of γ- Fe2O3@SiO2 Core Shell Nanoparticles: When the Coating Matters. J Phys Chem C. 2011; 116 (3):2285-91. doi: 10.1021/jp2086413
25. Moghimi SM, Andersen AJ, Hashemi SH, Lettiero B, Ahmadvand D, Hunter AC, et al. Complement activation cascade triggered by PEG-PL engineered nanomedicines and carbon nanotubes: The challenges ahead. J Control Release. 2010; 146(2):175-81. doi: 10.1016/j.jconrel.2010.04.003 PMID: 20388529
26. Cedervall T, Lynch I, Foy M, Berggård T, Donnelly SC, Cagney G, et al. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed Engl. 2007; 46:5754-6. doi: 10.1002/anie.200700465 PMID: 17591736
27. Kreuter J, Shamenkov D, Petrov V, Ramge P, Cychutek K, Koch-Brandt C, et al. Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier. J Drug Target. 2002; 10 (4):317-25. doi: 10.1080/10611860290031877 PMID: 12164380
28. Jedlovszky-Hajdú A, Bombelli FB, Monopoli MP, Tombácz E, Dawson KA. Surface Coatings Shape the Protein Corona of SPIONs with Relevance to Their Application in Vivo. Langmuir. 2012; 28 (42):14983-91. doi: 10.1021/la302446h PMID: 23002920
29. Sakulkhu U, Mahmoudi M, Maurizi L, Salaklang J, Hofmann H. Protein Corona Composition of Superparamagnetic Iron Oxide Nanoparticles with Various Physico-Chemical Properties and Coatings. Sci Rep. 2014;4. doi: 10.1038/srep05020
30. Ehrenberg MS, Friedman AE, Finkelstein JN, Oberdörster G, McGrath JL. The influence of protein adsorption on nanoparticle association with cultured endothelial cells. Biomaterials. 2009; 30:603-10. doi: 10.1016/j.biomaterials.2008.09.050 PMID: 19012960
31. Simberg D, Park J-H, Karmali PP, Zhang W-M, Merkulov S, McCrae K, et al. Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance. Biomaterials. 2009; 30:3926-33. doi: 10.1016/j.biomaterials.2009.03.056 PMID: 19394687
32. Karmali PP, Simberg D. Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems. Expert Opin Drug Deliv. 2011; 8(3):343-57. doi: 10.1517/ 17425247.2011.554818 PMID: 21291354
33. Walkey CD, Olsen JB, Song F, Liu R, Guo H, Olsen DWH, et al. Protein Corona Fingerprinting Predicts the Cellular Interaction of Gold and Silver Nanoparticles. ACS Nano. 2014; 8(3):2439-55. doi: 10.1021/ nn406018q PMID: 24517450
34. Farrera C, Fadeel B. It takes two to tango: Understanding the interactions between engineered nanomaterials and the immune system. Eur J Pharm Biopharm. 2015; 11(15):00138-1. doi: 10.1016/j.ejpb. 2015.03.007
35. Mahon E, Salvati A, Baldelli Bombelli F, Lynch I, Dawson KA. Designing the nanoparticle-biomolecule interface for targeting and therapeutic delivery. J Control Release. 2012; 161(2):164-74. doi: 10. 1016/j.jconrel.2012.04.009 PMID: 22516097